Publications
- Influence of albuminemia on the pharmacokinetics of infliximab in patients with inflammatory bowel diseases2011 | First Faculty of Medicine
- Serum infliximab trough levels and induction of antibodies to infliximab in patients with inflammatory bowel diseases2011 | First Faculty of Medicine
- Anticarbohydrate antibodies as markers of inflammatory bowel disease in a Central European cohort2010 | First Faculty of Medicine
- Infliximab trough levels may predict sustained response to infliximab in patients with Crohn's diseasePublication without faculty affiliation
- Antiphospholipid antibody isotypes and target autoantigen subgroups as predictors for different clinical manifestations of antiphospholipid syndromePublication without faculty affiliation
- Relationship Between Serum Trough Infliximab Levels and Serum Albumin in Patients With Inflammatory Bowel DiseasesPublication without faculty affiliation
- A switch from originator-adalimumab to the biosimilar SB5 in patients with Crohn's disease: an analysis of two propensity score-matched cohorts2022 | Faculty of Physical Education and Sport, First Faculty of Medicine
- Telemedicine and inflammatory bowel disease - results of the IBD Assistant pilot project2020 | Faculty of Physical Education and Sport, First Faculty of Medicine
- Iron substitution in sideropenia or sideropenic anemia in patients with IBD with heme iron containing preparation2020 | First Faculty of Medicine, Central Library of Charles University
- Biosimilar adalimumab in clinical practice2020 | First Faculty of Medicine
Loading network view...
